Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 27 3
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/15/2021 12 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Glucocorticoid therapy Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/18/2020 4 0
Procyanidin Potential treatment - theoretical effect Natural product Antiviral Sep/22/2020 1 0
Statin (general) Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/17/2020 1 0
RTAM-PAP1 Potential treatment - theoretical effect Experimental Antiviral Sep/17/2020 1 0